Rumi Scientific

Rumi Scientific is a biotechnology company operating in the New York artificial intelligence sector[1]. Founded in 2017, the company focuses on drug discovery and development of treatments for human genetic diseases affecting the central nervous system[2]. The company operates a human organoid-based platform designed for drug discovery applications that can be scaled to high-throughput screening levels[2]. According to available information, Rumi Scientific has approximately 17 employees[3].

Something wrong or missing? Send a correction. Fixed within 24 hours.